Study on P16 gene in acute leukemia

Abstract

To stddy the chang of suppressing cancer gene P16 in acute leukemia, the P16 antigen expression of leukemia cell surfaces in 61 cases were investigated with ABC assay and gene structural defects in 51 cases of acute leukemia were examined with multiple comparative PCR method. It was found that antigen expression of P16 in leukemia was obviously lower than that innormal subjects (P < 0.001). At the same time, antigen expression in All was lower than that AML (P < 0.05). No significant difference was found betwee the complete reission (CR) and non-remission (NR) subjects from AML and ALL groups (P > 0.05). THe exon 2 of P16 gene showed homozygous deletion only inn4 cases out of 30 cases in ALL. No stuctural defect was revealed in 21 cases of AML. It was suggested that expression defect of P16 gene was a main cause in development and progression of acute leukemia, and structural defect of exon 2 was not a primary molecular event.

Keywords

acute leukemia / P16 gene

References

[1] P53, P16 Bcl-2/JH 1997, 5:253

[2] ChenY, YuD J, LiC Y, et al.. Detection of surface antigen expression of preand post-cultured normal adult’s bone marrow cells by using ABC technique and its significance. Tongji Med Univ, 1992, 12: 179-179

[3] P16 1996, 19:358

[4] HaiderM A, CanX B, ManshouriT, et al.. P16INK4A and P15INK4B gene deletion in primary leukemias. Blood, 1995, 86: 311-311

[5] OgawaS, HangaishiA, MiyawakiS, et al.. Loss of the cyclin-dependent kinase 4-inhibitor (P16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood, 1995, 86: 1548-1548

[6] RochlitzC F, LohriA, Sasse-RothG, et al.. MTS1 expression and prognosis in acute myeloid leukemia. Ann Hematol, 1997, 75: 141-141